Allscripts Healthcare Solutions Inc (MDRX) Stake Boosted by Teachers Advisors LLC

Share on StockTwits

Teachers Advisors LLC lifted its position in shares of Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) by 0.6% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 921,374 shares of the software maker’s stock after purchasing an additional 5,830 shares during the quarter. Teachers Advisors LLC’s holdings in Allscripts Healthcare Solutions were worth $13,130,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Raymond James & Associates increased its stake in shares of Allscripts Healthcare Solutions by 77.1% during the 2nd quarter. Raymond James & Associates now owns 102,142 shares of the software maker’s stock worth $1,226,000 after purchasing an additional 44,472 shares during the last quarter. Seven Eight Capital LP bought a new stake in shares of Allscripts Healthcare Solutions during the 3rd quarter worth approximately $986,000. Mizuho Securities USA LLC bought a new stake in shares of Allscripts Healthcare Solutions during the 3rd quarter worth approximately $970,000. Avestar Capital LLC lifted its holdings in shares of Allscripts Healthcare Solutions by 24.1% during the 3rd quarter. Avestar Capital LLC now owns 20,051 shares of the software maker’s stock worth $270,000 after acquiring an additional 3,899 shares during the period. Finally, First Trust Advisors LP increased its position in Allscripts Healthcare Solutions by 129.5% during the 3rd quarter. First Trust Advisors LP now owns 143,024 shares of the software maker’s stock worth $2,038,000 after purchasing an additional 80,698 shares in the last quarter.

In other Allscripts Healthcare Solutions news, President Richard J. Poulton sold 60,000 shares of the stock in a transaction on Thursday, December 13th. The stock was sold at an average price of $9.82, for a total value of $589,200.00. Following the sale, the president now owns 479,520 shares in the company, valued at $4,708,886.40. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, insider Brian Farley sold 6,000 shares of the firm’s stock in a transaction on Friday, January 18th. The shares were sold at an average price of $12.00, for a total value of $72,000.00. Following the transaction, the insider now owns 235,673 shares in the company, valued at approximately $2,828,076. The disclosure for this sale can be found here. Insiders have bought a total of 37,728 shares of company stock valued at $380,972 over the last quarter. Corporate insiders own 1.10% of the company’s stock.

Allscripts Healthcare Solutions stock traded up $0.17 during midday trading on Monday, hitting $11.53. The stock had a trading volume of 33,040 shares, compared to its average volume of 2,428,949. The company has a current ratio of 0.94, a quick ratio of 0.94 and a debt-to-equity ratio of 1.61. Allscripts Healthcare Solutions Inc has a 52-week low of $8.54 and a 52-week high of $14.97. The firm has a market capitalization of $1.98 billion, a price-to-earnings ratio of 24.53, a P/E/G ratio of 1.68 and a beta of 1.40.

Several brokerages have issued reports on MDRX. JPMorgan Chase & Co. cut shares of Allscripts Healthcare Solutions from an “overweight” rating to a “neutral” rating and decreased their price target for the company from $16.00 to $12.00 in a research report on Friday, November 2nd. ValuEngine lowered shares of Allscripts Healthcare Solutions from a “hold” rating to a “sell” rating in a research note on Friday, November 2nd. SunTrust Banks lowered shares of Allscripts Healthcare Solutions from a “buy” rating to a “hold” rating in a research note on Friday, November 2nd. Cantor Fitzgerald lowered shares of Allscripts Healthcare Solutions from an “overweight” rating to a “neutral” rating and set a $12.00 price objective on the stock. in a research note on Thursday, November 1st. Finally, Citigroup lowered their target price on shares of Allscripts Healthcare Solutions from $19.00 to $17.00 and set a “buy” rating for the company in a report on Friday, November 2nd. Seven equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. Allscripts Healthcare Solutions presently has a consensus rating of “Buy” and a consensus price target of $15.31.

COPYRIGHT VIOLATION NOTICE: This report was published by Week Herald and is the sole property of of Week Herald. If you are viewing this report on another website, it was copied illegally and reposted in violation of US and international trademark & copyright legislation. The original version of this report can be viewed at https://weekherald.com/2019/02/11/allscripts-healthcare-solutions-inc-mdrx-stake-boosted-by-teachers-advisors-llc.html.

About Allscripts Healthcare Solutions

Allscripts Healthcare Solutions, Inc provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records, connectivity, private cloud hosting, outsourcing, analytics, patient engagement, clinical decision support, and population health management solutions.

Read More: Cash Flow

Want to see what other hedge funds are holding MDRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Allscripts Healthcare Solutions Inc (NASDAQ:MDRX).

Institutional Ownership by Quarter for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Receive News & Ratings for Allscripts Healthcare Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply